Acute Middle East Respiratory Syndrome Coronavirus Infection in Livestock Dromedaries, Dubai, 2014 - Volume 21, Number 6—June 2015 - Emerging Infectious Disease journal - CDC
Volume 21, Number 6—June 2015
Dispatch
Acute Middle East Respiratory Syndrome Coronavirus Infection in Livestock Dromedaries, Dubai, 2014
On This Page
Ulrich Wernery , Victor M. Corman, Emily Y.M. Wong, Alan K.L. Tsang, Doreen Muth, Susanna K. P. Lau, Kamal Khazanehdari, Florian Zirkel, Mansoor Ali, Peter Nagy, Jutka Juhasz, Renate Wernery, Sunitha Joseph, Ginu Syriac, Shyna K. Elizabeth, Nissy Annie Georgy Patteril, Patrick C. Y. Woo, and Christian Drosten
Abstract
Camels carry Middle East respiratory syndrome coronavirus, but little is known about infection age or prevalence. We studied >800 dromedaries of all ages and 15 mother–calf pairs. This syndrome constitutes an acute, epidemic, and time-limited infection in camels <4 years of age, particularly calves. Delayed social separation of calves might reduce human infection risk.
Middle East respiratory syndrome coronavirus (MERS-CoV) causes outbreaks and isolated cases of severe respiratory disease in humans. The virus is transmissible from human to human, but the focus of infection has remained in countries on the Arabian Peninsula. Recent reports have shown that dromedaries (Camelus dromedarius) across the Arabian Peninsula and parts of eastern and northern Africa have MERS-CoV antibodies (1–4). Virus detection by reverse transcription PCR (RT-PCR) and sequencing has confirmed that these antibodies are likely to be caused by infection with the same virus strains that infect humans (5). In singular cases, strong evidence for virus transmission between camels and humans was found (6,7). Infection of dromedaries in the laboratory has confirmed susceptibility and efficient shedding (8). MERS-CoV antibodies were not found in other species of livestock and leisure animals, including cattle, goats, sheep, and horses (9).
In the absence of a MERS-CoV vaccine, the prevention of human infections relies on knowledge of acute infection in camels. Available serologic studies indicate a high prevalence of MERS-CoV in adult camels, suggesting that MERS-CoV infection in camels may target young animals (1–4). However, only limited data on the age of animals at infection and the degree of age-specificity are available (5).
To best approximate the actual infectivity of virus in camels, testing should include RT-PCR and systematic virus isolation in cell culture (10). We recently analyzed a small group of camels in Saudi Arabia and found signs of recent acute MERS-CoV infection by demonstrating seroconversion, indicating a method for the serologic diagnosis of acute infection (7). To increase knowledge of acute MERS-CoV in dromedaries, we analyzed acute- and convalescent-phase MERS-CoV infections in similarly sized groups of camels of the same age in Dubai, United Arab Emirates.
Dr. Wernery, a veterinary microbiologist, is head of the Central Veterinary Research Laboratory in Dubai, United Arab Emirates. His main research interest is infectious diseases of livestock, in particular camels, of the Arabian Peninsula.
Acknowledgments
We thank Monika Eschbach-Bludau, Sebastian Brünink, Tobias Bleicker, and Artem Siemens for excellent technical assistance.
This work was partly supported by the Seed Funding for Theme-Based Research Scheme and Strategic Research Theme Fund, The University of Hong Kong; Research Grant Council Grant, University Grant Council; and Consultancy Service for Enhancing Laboratory Surveillance of Emerging Infectious Disease of the Hong Kong Special Administrative Region Department of Health. Work in Bonn was funded by the European Commission ANTIGONE (Anticipating the Global Onset of Novel Epidemics) project (contract no. 278976) and the Deutsche Forschungsgemeinschaft (grant DR 772/7-1 to C.D.).
References
- Reusken CB, Messadi L, Feyisa A, Ularamu H, Godeke GJ, Danmarwa A, Geographic distribution of MERS coronavirus among dromedary camels, Africa. Emerg Infect Dis. 2014;20:1370–4. DOIPubMed
- Meyer B, Muller MA, Corman VM, Reusken CB, Ritz D, Godeke GJ, Antibodies against MERS coronavirus in dromedary camels, United Arab Emirates, 2003 and 2013. Emerg Infect Dis. 2014;20:552–9. DOIPubMed
- Reusken CB, Haagmans BL, Muller MA, Gutierrez C, Godeke GJ, Meyer B, Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study. Lancet Infect Dis. 2013;13:859–66. DOIPubMed
- Müller MA, Corman VM, Jores J, Meyer B, Younan M, Liljander A, MERS coronavirus neutralizing antibodies in camels, eastern Africa, 1983–1997.Emerg Infect Dis. 2014;20:2093–5. DOIPubMed
- Alagaili AN, Briese T, Mishra N, Kapoor V, Sameroff SC, Burbelo PD, Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia. MBio. 2014;5:e00884–14. DOIPubMed
- Haagmans BL, Al Dhahiry SH, Reusken CB, Raj VS, Galiano M, Myers R, Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation. Lancet Infect Dis. 2014;14:140–5. DOIPubMed
- Memish ZA, Cotten M, Meyer B, Watson SJ, Alsahafi AJ, Al Rabeeah AA, Human Infection with MERS coronavirus after exposure to infected camels, Saudi Arabia, 2013. Emerg Infect Dis. 2014;20:1012–5 . DOIPubMed
- Adney DR, van Doremalen N, Brown VR, Bushmaker T, Scott D, de Wit E, Replication and shedding of MERS-CoV in upper respiratory tract of inoculated dromedary camels. Emerg Infect Dis. 2014;20:1999–2005. DOIPubMed
- Reusken CB, Ababneh M, Raj VS, Meyer B, Eljarah A, Abutarbush S, Middle East respiratory syndrome coronavirus (MERS-CoV) serology in major livestock species in an affected region in Jordan, June to September 2013. Euro Surveill. 2013;18:20662 .PubMed
- Raj VS, Farag EA, Reusken CB, Lamers MM, Pas SD, Voermans J, Isolation of MERS coronavirus from a dromedary camel, Qatar, 2014. Emerg Infect Dis. 2014;20:1339–42. DOIPubMed
- Drosten C, Meyer B, Muller MA, Corman VM, Al-Masri M, Hossain R, Transmission of MERS-coronavirus in household contacts. N Engl J Med.2014;371:828–35. DOIPubMed
- Corman VM, Jores J, Meyer B, Younan M, Liljander A, Said MY, Antibodies against MERS coronavirus in dromedary camels, Kenya, 1992–2013.Emerg Infect Dis. 2014;20:1319–22. DOIPubMed
- Corman VM, Eckerle I, Bleicker T, Zaki A, Landt O, Eschbach-Bludau M, Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction. Euro Surveill. 2012;17:20285 .PubMed
- Drosten C, Muth D, Corman VM, Hussain R, Al Masri M, Hajomar W, An observational, laboratory-based study of outbreaks of MERS-coronavirus in Jeddah and Riyadh, Kingdom of Saudi Arabia, 2014. Clin Infect Dis. 2015;60:369–77 .PubMed
- Hemida MG, Chu DK, Poon LL, Perera RA, Alhammadi MA, Ng HY, MERS coronavirus in dromedary camel herd, Saudi Arabia. Emerg Infect Dis.2014;20:1231–4. DOIPubMed
Figure
Tables
Suggested citation for this article: Wernery U, Corman VM, Wong EYM, Tsang AKL, Muth D, Lau SKP, et al. Acute Middle East respiratory syndrome coronavirus infection in livestock dromedaries, Dubai, 2014. Emerg Infect Dis. 2015 Jun [date cited]. http://dx.doi.org/10.3201/eid2106.150038
No hay comentarios:
Publicar un comentario